These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15121755)

  • 1. A pilot phase II study of capecitabine in advanced or recurrent colorectal cancer.
    Kondo Y; Terashima M; Sato A; Taguchi T
    Jpn J Clin Oncol; 2004 Apr; 34(4):195-201. PubMed ID: 15121755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II Study of the global dose and schedule of capecitabine in Japanese patients with metastatic colorectal cancer.
    Hyodo I; Shirao K; Doi T; Hatake K; Arai Y; Yamaguchi K; Tamura T; Takemiya S; Takiuchi H; Nakagawa K; Mishima H
    Jpn J Clin Oncol; 2006 Jul; 36(7):410-7. PubMed ID: 16825251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot phase II study of capecitabine in advanced or recurrent breast cancer.
    Saeki T; Kimura T; Toi M; Taguchi T
    Breast Cancer; 2006; 13(1):49-57. PubMed ID: 16518062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer.
    Hong YS; Song SY; Lee SI; Chung HC; Choi SH; Noh SH; Park JN; Han JY; Kang JH; Lee KS; Cho JY
    Ann Oncol; 2004 Sep; 15(9):1344-7. PubMed ID: 15319239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors.
    Saeki T; Takashima S; Terashima M; Satoh A; Toi M; Osaki A; Toge T; Ohno S; Nomura N; Fukuyama Y; Koizumi W; Taguchi T
    Int J Clin Oncol; 2005 Feb; 10(1):51-7. PubMed ID: 15729602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer.
    Kusama M; Nomizu T; Aogi K; Yoshimoto M; Horikoshi N; Tabei T; Noguchi S; Miura S; Yoshimura N; Kimura M; Toyama K; Shin E
    Breast Cancer; 2010 Oct; 17(4):233-40. PubMed ID: 19633909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II Japanese study of a modified capecitabine regimen for advanced or metastatic colorectal cancer.
    Sakamoto J; Kondo Y; Takemiya S; Sakamoto N; Nishisho I;
    Anticancer Drugs; 2004 Feb; 15(2):137-43. PubMed ID: 15075669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of a 4-week capecitabine regimen in advanced or recurrent gastric cancer.
    Sakamoto J; Chin K; Kondo K; Kojima H; Terashima M; Yamamura Y; Tsujinaka T; Hyodo I; Koizumi W;
    Anticancer Drugs; 2006 Feb; 17(2):231-6. PubMed ID: 16428943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: a Korean Cancer Study Group trial.
    Kim TW; Kang WK; Chang HM; Park JO; Ryoo BY; Ahn JS; Zang DY; Lee KH; Kang YK; Kim SR; Kim HK;
    Acta Oncol; 2005; 44(3):230-5. PubMed ID: 16076694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot phase II study of capecitabine in advanced or recurrent gastric cancer.
    Koizumi W; Saigenji K; Ujiie S; Terashima M; Sakata Y; Taguchi T;
    Oncology; 2003; 64(3):232-6. PubMed ID: 12697963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.
    Lee JJ; Kim TM; Yu SJ; Kim DW; Joh YH; Oh DY; Kwon JH; Kim TY; Heo DS; Bang YJ; Kim NK
    Jpn J Clin Oncol; 2004 Jul; 34(7):400-4. PubMed ID: 15342667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.
    Van Cutsem E; Twelves C; Cassidy J; Allman D; Bajetta E; Boyer M; Bugat R; Findlay M; Frings S; Jahn M; McKendrick J; Osterwalder B; Perez-Manga G; Rosso R; Rougier P; Schmiegel WH; Seitz JF; Thompson P; Vieitez JM; Weitzel C; Harper P;
    J Clin Oncol; 2001 Nov; 19(21):4097-106. PubMed ID: 11689577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capecitabine: a review.
    Walko CM; Lindley C
    Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.
    Gajria D; Gonzalez J; Feigin K; Patil S; Chen C; Theodoulou M; Drullinsky P; D'Andrea G; Lake D; Norton L; Hudis CA; Traina TA
    Breast Cancer Res Treat; 2012 Jan; 131(1):111-6. PubMed ID: 21898114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study.
    Akgun Z; Saglam S; Yucel S; Gural Z; Balik E; Cipe G; Yildiz S; Kilickap S; Okyar A; Kaytan-Saglam E
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):751-6. PubMed ID: 25102935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimen.
    Streit M; Jaehde U; Stremetzne S; Ridwelski K; Kerz H; Strohbach F; Hohenberger P; Zwiebel FM; Hebart H; Böthig R; Kairies M; Zillig D; Schuchmann S; Warnecke S; Thiel E; Kreuser ED
    Ann Oncol; 1997 Nov; 8(11):163-5. PubMed ID: 9426339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?
    Glynne-Jones R; Dunst J; Sebag-Montefiore D
    Ann Oncol; 2006 Mar; 17(3):361-71. PubMed ID: 16500912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients].
    Yamaguchi T; Fukuda M; Yasui H; Okazaki S; Kubo K; Tanaka M; Une Y; Setoguchi Y; Hanada K; Moriyama S; Tani M; Murakami T; Okuchi Y; Ogiso S; Hata H; Sakata S; Otani T; Yamato T; Ikai I
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):389-93. PubMed ID: 22421765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study.
    Feliu J; Escudero P; Llosa F; Bolaños M; Vicent JM; Yubero A; Sanz-Lacalle JJ; Lopez R; Lopez-Gómez L; Casado E; Gómez-Reina MJ; González-Baron M
    J Clin Oncol; 2005 May; 23(13):3104-11. PubMed ID: 15860870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capecitabine: a review of its pharmacology and therapeutic efficacy in the management of advanced breast cancer.
    Wagstaff AJ; Ibbotson T; Goa KL
    Drugs; 2003; 63(2):217-36. PubMed ID: 12515569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.